Other languages MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Real-time Estimate Cboe BZX Other stock markets 07:11:22 01/05/2024 pm IST			5-day change	1st Jan Change
4.97 ^USD	+1.84%		-1.01%	-30.48%

16/04	MeiraGTx Holdings plc Appoints Dr. Debra Yu to Serve on Each of the Compensation Committee and Science and Technology Committee of the Board	CI
14/03	MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MeiraGTx Holdings plc Appoints Dr. Debra Yu to Serve on Each of the Compensation Committee and Science and Technology Committee of the Board	17/04
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Who are OpenAI's new board members?	11/03
MeiraGTx to Receive $50 Million Milestone Payment from J&J's Janssen Under Bota-Vec Deal	13/02
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	22/12
Sector Update: Health Care Stocks Advance in Afternoon Trading	22/12
MeiraGTx Holdings Shares Rise on Sale of Remaining Bota-vec Interests to Janssen Pharmaceuticals for Up to $415 Million	21/12
MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
MeiraGT Receives $30 Million Strategic Investment from Sanofi; to Seek Further Strategic Opportunities	30/23/30
Sanofi investit 30 millions de dollars dans MeiraGTx	30/23/30
Top Premarket Gainers	30/23/30
MeiraGTx Holdings plc Announces an Oral Presentation and Eight Posters At the European Society of Gene and Cell Therapy 2023 Annual Congress	24/23/24
MeiraGTx Holdings plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10
MeiraGTx Gets Irish Regulator's Authorization for Quality Control Testing at Manufacturing Facility	19/23/19
MeiraGTx Says Treatment Candidate for Dry Mouth Improved Symptoms in Phase 1 Trial	27/23/27
MeiraGTx Holdings plc Announces Positive Clinical Data from the AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia	27/23/27
MeiraGTx Holdings plc to Present 12-Month Data from All Cohorts of the Completed Phase 1 AQUAx Clinical Study	23/23/23
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11
Meiragtx Holdings plc Announces Resignation of Arnold J. Levine from the Board of Directors and the Committees of the Board	27/23/27
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Other languages

Filters